Latest news with #GregSamios
Business Wire
2 days ago
- Business
- Business Wire
Wolters Kluwer Again Recognized as Clinical Decision Support Leader
WALTHAM, Mass.--(BUSINESS WIRE)-- Wolters Kluwer Health has once again been identified as one of the top two companies in the new Frost Radar™ report on Clinical Decision Support Systems (CDSS). Evaluating over 60 companies, the Frost Radar spotlights 10; Wolters Kluwer was the only one named both a 'Company to Action' and the market leader for innovation. The company was also a leader in the 2023 report. Wolters Kluwer Health has been identified as one of the top two companies in the new Frost Radar™ report on Clinical Decision Support Systems (CDSS) and the only one named both a 'Company to Action' and the market leader for innovation. Share According to the Frost report, the top-right Radar position of Wolters Kluwer shows it 'has firmly established itself as a leader in the CDSS market, with impressive R&D investment, and recent and upcoming product launches. The company's strategic integration of emerging technologies, particularly Gen AI, has positioned it at the forefront of next-generation CDSS solutions.' The report also recognizes the company's redefinition of the CDSS category with its introduction of UpToDate Enterprise Edition stating it 'is designed to align buyers, administrators, and care teams on a singular platform. This strategic alignment is key in enhancing care delivery and realizing superior returns on investment. With advanced on-demand analytics, this edition offers system-level insights into product usage, community trends, education needs, and the overarching impact of UpToDate on healthcare systems.' 'The Frost Radar is a deep dive into the CDSS market and its vendors. Based on our analysis, Wolters Kluwer has achieved significant growth for its solutions by focusing on innovation and customer-centric solutions,' said Dr. Rishi Pathak, Global Director of Healthcare & Life Sciences, Frost & Sullivan. 'That, combined with their strategy to increase the reach of UpToDate through integration into the clinician workflow and the intention to address adjacent operational and financial workflows, puts them in the leadership position.' Wolters Kluwer Health recently announced the integration of UpToDate with several ambient AI leaders, including Abridge, Suki, Microsoft and others. 'Being named the innovation leader in the Frost Radar reinforces our focus on innovation and interconnectivity and validates our commitment to transforming healthcare through product innovation and strategic partnerships,' said Greg Samios, CEO of Wolters Kluwer Health. 'We remain dedicated to helping providers make faster, smarter decisions across the care continuum, while enabling organizations to maximize their UpToDate investment through insightful analytics, harmonized content, seamless integration, and AI-enhanced features.' Learn more about Wolters Kluwer in the Frost Radar on CDSS. About Wolters Kluwer Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services. Wolters Kluwer reported 2024 annual revenues of €5.9 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,600 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. For more information, visit follow us on LinkedIn, Facebook, YouTube and Instagram.
Business Wire
3 days ago
- Business
- Business Wire
Wolters Kluwer Future Ready Healthcare Survey Report Reveals Significant Opportunity for Healthcare GenAI—If Health Systems Can Overcome the Readiness Gap
WALTHAM, Mass.--(BUSINESS WIRE)--The new 2025 Future Ready Healthcare Survey Report from Wolters Kluwer Health, conducted in partnership with the independent marketing research firm Ipsos, reveals that while healthcare professionals widely recognize the transformative potential of generative AI (GenAI), most organizations are not yet ready to harness its full value. Wolters Kluwer Health/Ipsos survey reveals most healthcare organizations are not yet ready to harness the full value of GenAI, despite interest among professionals. Share The survey identifies strong enthusiasm for using GenAI to address the current challenges of workforce shortages, burnout, high healthcare costs, and rising administrative burdens, as well as keen interest in leveraging GenAI to achieve the next level of innovation and efficiency across the enterprise. However, the data also shows a clear disconnect between what organizations say they want to achieve with GenAI and how prepared they are to deliver on that promise. For example, while 80% of respondents cited 'optimizing workflows' as a top organizational goal, only 63% feel prepared to use GenAI to do so. 'GenAI has the potential to be a powerful tool for supporting sustainability in healthcare organizations right now, as well as preparing them for a more efficient future,' said Greg Samios, CEO of Wolters Kluwer Health. 'The challenge is developing a strategy that can both optimize the current state in a highly volatile environment and simultaneously equip organizations with the digital capabilities they need to remain competitive over the next several years. Right now, organizations are at risk of falling behind unless they take a more cohesive approach to making GenAI standardized, scalable, and impactful.' Key Findings: Nurse staffing and workforce concerns are at the top of the priority list for health GenAI applications: 85% of respondents cited 'recruiting/retaining nursing staff' as a top priority, while 76% identified 'reducing clinician burnout' as a main concern. Leaders are focusing on the basics to keep the enterprise running: GenAI-driven technologies are likely to be part of the solution for longstanding challenges, such as addressing the burdens of prior authorizations (67%), electronic health record (EHR) management (62%), cybersecurity preparedness (68%), and supporting telehealth/virtual care programs (65%). But clinical staff expect more from the GenAI revolution: In qualitative responses, participants said they understand and acknowledge the need for workflow optimization but also want to see innovative capabilities such as ambient listening, clinical decision support leveraging GenAI, and assistance with communication and documentation utilizing GenAI. Formal GenAI policies and guidance are scarce: Only 18% of respondents were aware of formal organizational policies governing GenAI use, and only 1 in 5 reported being required to take structured training. As a result, concerns about appropriate implementation persist: More than half (57%) believe that overreliance on GenAI may erode clinical decision-making skills, while 55% are concerned that lack of transparency around GenAI's potential role in making diagnoses could contribute to unclear reasoning behind patient-facing decisions. 'To successfully integrate GenAI, organizations must recognize its current limitations, as well as anticipate its realistic evolution and the regulatory landscape,' said Dr. Peter Bonis, Chief Medical Officer, Wolters Kluwer Health. 'It is also vital to select GenAI applications that align with both clinical and financial goals while fitting into existing workflows. Establishing robust and ongoing governance will be essential to succeed.' About the Wolters Kluwer 2025 Future Ready Healthcare Survey Report The 2025 Future Ready Healthcare Survey Report is based on a nationally representative survey conducted by Ipsos, an independent marketing research firm, in early 2025. Respondents included physicians, nurses, pharmacists, allied health professionals, administrators, and medical librarians across the US. Download the 2025 Future Ready Healthcare Survey Report to read more. About Wolters Kluwer Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services. Wolters Kluwer reported 2024 annual revenues of €5.9 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,600 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. For more information, visit follow us on LinkedIn, Facebook, YouTube and Instagram.
Yahoo
29-05-2025
- Business
- Yahoo
Wolters Kluwer appoints Greg Samios as CEO of Health division
PRESS RELEASE Wolters Kluwer appoints Greg Samios as CEO of Health division Experienced healthcare executive has track record of driving innovation and delivering results Alphen aan den Rijn — May 29, 2025 — Wolters Kluwer, a global leader in information solutions, software, and services for professionals, has named Greg Samios as Chief Executive Officer of its Health division, effective June 1. Samios succeeds Stacey Caywood, who became a Member of the Executive Board of Wolters Kluwer on May 15, 2025. A seasoned healthcare executive with more than twenty-five years of experience, Samios has served as Executive Vice President of the Health division's two largest business units, Clinical Effectiveness and Health Learning, Research, and Practice. While a Health division leader, Samios has driven growth in Wolters Kluwer's leading clinical decision support and clinical drug information products, UpToDate and Medi-Span. He also led the introduction of generative AI into the company's healthcare products and solidified partnerships with leading digital health companies. In a prior role at Wolters Kluwer, Samios served as Executive Vice President of the Legal & Regulatory U.S. business. His career experience before joining Wolters Kluwer included several health-focused positions at Elsevier spanning more than ten years. He earned a Master of Business Administration from Duke University Fuqua School of Business and graduated with a B.S. and M.S. in Engineering from the University of Rochester. 'We are delighted to name Greg Samios as the new CEO of Wolters Kluwer Health,' said Nancy McKinstry, Chief Executive Officer and Chair of the Executive Board for Wolters Kluwer. 'Our large, global Health division requires an experienced leader to continue driving innovation and adapting to market challenges. We are confident that Greg has the right combination of experience and passion to deliver on our strategy and drive incremental value for our customers and growth for our business.' Wolters Kluwer Health supports professionals across healthcare with trusted advanced technology, evidence-based solutions, research, and life-long learning. ###About Wolters KluwerWolters Kluwer (EURONEXT: WKL) is a global leader in information solutions, software and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services. Wolters Kluwer reported 2024 annual revenues of €5.9 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,900 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX, Euro Stoxx 50 and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt (ADR) program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY). For more information, visit follow us on LinkedIn, Facebook, YouTube and Instagram. Media Investor/Analyst Stefan Kloet Meg Geldens Associate Director Vice President Global Communications Investor Relations press@ ir@ t: +316 1233 657 Andre Rebelo Wolters Kluwer Health Director, External Communications t: +1 781 392 2411 Forward-looking Statements and Other Important Legal InformationThis report contains forward-looking statements. These statements may be identified by words such as 'expect', 'should', 'could', 'shall' and similar expressions. Wolters Kluwer cautions that such forward-looking statements are qualified by certain risks and uncertainties that could cause actual results and events to differ materially from what is contemplated by the forward-looking statements. Factors which could cause actual results to differ from these forward-looking statements may include, without limitation, general economic conditions; conditions in the markets in which Wolters Kluwer is engaged; conditions created by pandemics; behavior of customers, suppliers, and competitors; technological developments; the implementation and execution of new ICT systems or outsourcing; and legal, tax, and regulatory rules affecting Wolters Kluwer's businesses, as well as risks related to mergers, acquisitions, and divestments. In addition, financial risks such as currency movements, interest rate fluctuations, liquidity, and credit risks could influence future results. The foregoing list of factors should not be construed as exhaustive. Wolters Kluwer disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Attachment 2025.05.29 Wolters Kluwer appoints Greg Samios as CEO of Health divisionSign in to access your portfolio
Yahoo
04-03-2025
- Health
- Yahoo
Wolters Kluwer to Integrate UpToDate Into Healthcare Agent Service in Microsoft Copilot Studio
Collaboration uses GenAI to deliver patient-specific, evidence-based medical content through Microsoft Dragon Copilot ambient listening and other point of care workflows WALTHAM, Mass., March 04, 2025--(BUSINESS WIRE)--Wolters Kluwer Health is integrating its UpToDate solution with the healthcare agent service in Microsoft Copilot Studio. This integration aims to explore and validate the use of GenAI to provide clinicians with relevant and patient-specific evidence-based content from UpToDate® at the point of care. The Microsoft healthcare agent service is designed to empower healthcare technology developers to build and deploy generative AI-based healthcare agents. "Every day, healthcare organizations and clinicians depend on UpToDate to provide answers to clinical questions when caring for patients. By collaborating with Microsoft to incorporate UpToDate content into their healthcare agent service, we are pioneering new ways to provide healthcare organizations with trusted, evidence-based answers in real-time—where it best meets their needs. We believe these efforts together will help provide clinicians with new resources to alleviate administrative burdens and spend more time with patients," said Greg Samios, President and CEO of Clinical Effectiveness for Wolters Kluwer Health. UpToDate is a Clinical Decision Support (CDS) solution used by over three million clinicians around the world and many of the world's largest healthcare systems. For over 30 years, clinicians and care teams have trusted UpToDate for clear answers and recommendations to support their treatment of patients. UpToDate content is powered by the medical knowledge and clinical expertise of the world's leading physicians. The UpToDate editorial team consists of authors and contributors who bring deep domain expertise and collaborate with a global team of physician editors and peer reviewers to deliver evidence and recommendations that are in-depth, clear, and actionable. Healthcare agent service in Microsoft Copilot Studio enables healthcare organizations to develop their own generative AI-powered agents, providing reusable healthcare-specific features, templates, pre-built healthcare intelligence from credible sources, extensibility via plugins and integration with customer-provided sources with healthcare-adapted safeguards. When exploring these high-value use cases, both companies will prioritize a responsible approach to GenAI. The first joint project will focus on Microsoft's first-party applications, notably Microsoft Dragon Copilot, to validate the integration of real-time GenAI content from UpToDate in supporting clinical decisions within ambient and voice-enabled clinical documentation workflows. "We are exploring integration into our healthcare agent service in Microsoft Copilot Studio to enable a broad set of high-value use cases for our customers, including within our Microsoft Dragon Copilot solution," says Hadas Bitran, GM Health AI in Microsoft Health & Life Sciences. "Our technology will use Wolters Kluwer's high-quality content to enrich sophisticated functionality that will enable high value use cases for our customers." For more information about Wolters Kluwer, please visit: About Wolters Kluwer Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services. Wolters Kluwer reported 2024 annual revenues of €5.9 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,400 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. For more information, visit follow us on LinkedIn, Facebook, YouTube and Instagram. View source version on Contacts Media Contact Suzanne MoranAssociate Director, External CommunicationsWolters Kluwer Health+1 (617) Sign in to access your portfolio
Yahoo
03-03-2025
- Business
- Yahoo
Wolters Kluwer and Suki to integrate UpToDate's trusted physician-authored content into Suki Assistant
Suki AI-powered ambient solution will include access to relevant UpToDate evidence-based content to help reduce the administrative burden for clinicians supporting better care for patients WALTHAM, Mass. & REDWOOD CITY, Calif., March 03, 2025--(BUSINESS WIRE)--Wolters Kluwer Health and Suki® are partnering to streamline administrative tasks for clinicians by making UpToDate®, a market-leading clinical decision support (CDS) solution, accessible from within Suki Assistant. Suki is a leader in healthcare AI that aims to make healthcare technology invisible and assistive so clinicians can focus on what's most important: their patients. Suki Assistant is an AI assistant that saves clinicians time and generates incremental revenue by automatically creating clinical notes ambiently, generating patient summaries, performing smart dictation, recommending codes to improve billing, and answering patient questions using data in the EHR. Beyond Suki Assistant, Suki's AI platform is used by many healthcare tech companies like Zoom, athenahealth, and others to power their AI experiences. Wolters Kluwer's UpToDate is one of the most trusted resources in healthcare, providing reliable clinical and drug information and evidence-based recommendations at the point of care. Clinicians using UpToDate will now have seamless access to clinical evidence directly within their Suki-generated notes—before, during, and after patient encounters. This integration empowers providers to make informed decisions at the point of care, reducing administrative burden and allowing them to focus more on meaningful patient interactions. This supports an improved experience for both clinicians and patients. "Clinicians rely on UpToDate to support their decision making and we are committed to ensuring they can access the content they need to help make the best decisions for each patient, wherever they are in the workflow. Through our partnership with Suki, we can help enrich clinical notes so clinicians can be more fully present with their patients," said Greg Samios, CEO Clinical Effectiveness for Wolters Kluwer Health. "We aim to continue to make Suki an ever-present, invisible assistant that not only streamlines clinical documentation, but also supports clinical reasoning for clinicians," said Punit Soni, CEO and Founder of Suki. "This partnership with Wolters Kluwer is a natural evolution of Suki's Q&A capability following our partnership with Google Cloud earlier this year. By integrating evidence-based clinical content from UpToDate, Suki empowers clinicians with reliable insights to support their decision-making and enhance treatment recommendations. This will over time be available both through Suki Assistant and Suki Platform." About Wolters Kluwer Wolters Kluwer (Euronext: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services. Wolters Kluwer reported 2024 annual revenues of €5.9 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,400 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX, Euro Stoxx 50 and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt (ADR) program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY). For more information, visit follow us on LinkedIn, Facebook, YouTube and Instagram. Learn more about UpToDate here. About Suki Suki is a leading technology company that provides AI voice solutions for healthcare. Its mission is to reimagine the healthcare technology stack, making it invisible and assistive to lift the administrative burden from clinicians. Its flagship product is Suki Assistant, an AI assistant that uses generative AI to automatically create clinical documentation by ambiently listening to patient-clinician conversations. Suki helps clinicians complete notes 72% faster on average, assists with other tasks including coding and answering questions, and generates incremental revenue for organizations, delivering a 9X ROI in year 1. Suki also offers its proprietary AI and speech platform, Suki Platform, to partners who want to create best-in-class ambient and voice experiences for their solutions. Suki is backed by premier investors such as Venrock, First Round, Flare Capital Partners, March Capital, and Hedosophia. To learn more, visit or follow us on LinkedIn and Twitter. View source version on Contacts Media Contacts Suzanne MoranAssociate Director, External CommunicationsWolters Kluwer Health+1 Suki Media Contact pr@
